Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

MUC1 expression in plasmacytoma.

S Paydaş¹, B Sahin, G Gönlüşen

¹Department of Oncology, Faculty of Medicine, Cukurova University, 01330 Balcali, Adana, Turkey. sepay@mail.cu.edu.tr

Leukemia Research

|February 28, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Incremental value of binary PSMA PET nodal status when added to Briganti-2019 and MSKCC models for predicting pathologic lymph node metastasis in prostate cancer.

Actas urologicas espanolas·2026

Same author

The effect of acute cold ischemia duration on testicular tissue.

BMC urology·2026

Same author

Comparison of the effectiveness of liposomal doxorubicin and gemcitabine in patients with platinum-sensitive recurrent ovarian cancer receiving third-line chemotherapy.

European review for medical and pharmacological sciences·2023

Same author

Comparison of different cyclin-dependent kinase inhibitors and KI-67 levels on survival and toxicity in breast cancer treatment.

European review for medical and pharmacological sciences·2023

Same author

Awareness and obscurity: demystifying genomic profiling in real-world practice for the members of the Turkish Society of Medical Oncology (TSMO).

European review for medical and pharmacological sciences·2023

Same author

Nasal secretory protein changes following intravenous choline administration in calves with experimentally induced endotoxaemia.

Veterinary immunology and immunopathology·2021

MUC1 expression in plasmacytoma (Pm) correlates with immature cell morphology, a key prognostic indicator. This suggests MUC1 may serve as an additional predictive marker for Pm progression to multiple myeloma.

Area of Science:

Hematology
Oncology
Molecular Pathology

Background:

Plasmacytoma (Pm) is a plasma cell (PC) neoplasm with potential progression to multiple myeloma.
Current indicators for predicting Pm progression are limited.
Histopathologic grade is an established prognostic factor in Pm.

Purpose of the Study:

To evaluate MUC1 expression in plasmacytoma cases.
To determine the predictive value of MUC1 expression in Pm.
To compare MUC1 expression with histopathologic grade and bone marrow (BM) involvement.

Main Methods:

Retrospective analysis of 31 plasmacytoma cases.
Assessment of MUC1 expression using immunohistochemistry.
Correlation of MUC1 expression with histopathologic morphology (mature vs. immature) and bone marrow involvement.

Related Experiment Videos

Main Results:

MUC1 expression was observed in 9 out of 31 Pm cases.
MUC1 expression was significantly associated with immature morphology (7/13 cases) compared to mature morphology (2/18 cases) (P<0.006).
A trend towards association between MUC1 expression and bone marrow involvement was noted, but it was not statistically significant.

Conclusions:

MUC1 expression is significantly associated with immature morphology in plasmacytoma.
Given the prognostic importance of immature morphology, MUC1 expression may serve as an additional prognostic indicator in Pm.
Further research is warranted to confirm MUC1's role in predicting Pm progression to multiple myeloma.